title: Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986-1991).
abstract: Medical records of 36 dogs with synovial sarcoma confirmed by microscopic examination of H&E-stained sections of tissue were selected for retrospective analysis from dogs admitted between 1986 and 1991 to participating institutions of the Veterinary Cooperative Oncology Group. Metastasis was evident at the time of diagnosis in 8 (22%) dogs, and 15 (41%) dogs ultimately developed metastatic tumors. Median survival time for all dogs, as determined by life-table analysis, was 17 months. For dogs that were subsequently treated and became tumor free, the median disease-free interval was 30 months. Nine dogs had previously had localized excision attempted, but all had recurrence of the tumor locally (median, 4.5 months). Of 29 dogs that underwent amputation, including the 9 with localized recurrence, 2 had tumor recurrence on the amputation stump. Most dogs had survival time and disease-free interval of > 36 months after amputation. Four dogs that had received chemotherapy for tumors of advanced clinical stages did not respond to treatment. One dog that had received locally applied radiotherapy after localized excision did not have evidence of tumor recurrence 2 years after radiotherapy. Clinical stage, histologic grade, and a positive result for tests that used cytokeratin immunohistochemical staining significantly (P < 0.05) influenced survival time and disease-free interval. Analysis of data for the study reported here suggested that histologic criteria can be an excellent predictor of dogs that are likely to have tumor recurrence after amputation and that would most likely benefit from aggressive treatment with adjuvants.
authors.affiliation: Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison 53706.
authors.forename: D M
authors.initials: DM
authors.lastname: Vail
authors.forename: B E
authors.initials: BE
authors.lastname: Powers
authors.forename: D M
authors.initials: DM
authors.lastname: Getzy
authors.forename: W B
authors.initials: WB
authors.lastname: Morrison
authors.forename: M C
authors.initials: MC
authors.lastname: McEntee
authors.forename: D A
authors.initials: DA
authors.lastname: O'Keefe
authors.forename: A M
authors.initials: AM
authors.lastname: Norris
authors.forename: S J
authors.initials: SJ
authors.lastname: Withrow
mesh_terms: D000671:Amputation, Surgical / Q000662:veterinary; D000818:Animals; D018572:Disease-Free Survival; D004283:Dog Diseases / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D004285:Dogs; D005260:Female; D015993:Life Tables; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D013584:Sarcoma, Synovial / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000662:veterinary*; D016019:Survival Analysis